| 摘要 |
<p>Novel agent for the propylaxis and treatment of heart failure, which comprises as an active ingredient a 2-oxo-imidazolidine compound of the formula: <CHEM> wherein R<1> and R<2> are the same or different and are each a lower alkyl group, R<3> is a phenyl-substituted lower alkyl group, and R<4> is hydrogen atom or a lower alkyl group, or a pharmaceutically acceptable salt thereof.</p> |
